Neurology

Hyperfine Announces European Launch with CE Approval

Myomo Reports Record Third Quarter Financial and Operating Results

Vistagen to Present at the 2024 Neuroscience Education Institute Congress

Starlight Therapeutics Announces Inaugural Members of Scientific Advisory B

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverag

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Da

Myomo to Report Third Quarter Financial Results on November 6, 2024

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Tr

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised t

Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV

BPGbio to Present New Data on BPM31510 and Novel Quinomics Technology for T

Epitel Expands AI Portfolio With A Fourth FDA 510(k) Clearance for REMI

First Photorealistic AI Avatar for People Living with Alzheimer’s and Dem

Cognito Therapeutics Publishes Study Demonstrating Structural Brain Preserv

Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms

VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artific

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutic

Cognito Therapeutics to Present New Data for Spectris™ in Alzheimer’s D

BPGbio to Present Novel Drug Target for Huntington’s Disease and AI Disco

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to